Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck
M. J. Awan, L. Nedzi, D. Wang, V. Tumati, B. Sumer, X. J. Xie, I. Smith, J. Truelson, R. Hughes, L. L. Myers, P. Lavertu, S. Wong, Min Yao
Dive into the research topics of 'Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.